Literature DB >> 25973735

Achromobacter xylosoxidans Bacteremia and Cellulitis: A Report of a Case.

Julia Dai1, Auris O Huen2, Lori A Kestenbaum3,4, Margaret D Sarezky4, Carrie C Coughlin5, Albert C Yan2,5.   

Abstract

Achromobacter xylosoxidans is a rare, opportunistic infection most commonly encountered in immunocompromised patients during hospitalization. Primary uncomplicated bacteremia, catheter-associated infections, and pneumonia have been reported as the most common clinical presentations; skin and soft tissue infections from A. xylosoxidans are rare. We describe a case of A. xylosoxidans presenting as cellulitis and bacteremia in an immunocompromised patient.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25973735      PMCID: PMC4642452          DOI: 10.1111/pde.12608

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  5 in total

1.  First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.

Authors:  Julien Bador; Lucie Amoureux; Jean-Marie Duez; Anthony Drabowicz; Eliane Siebor; Catherine Llanes; Catherine Neuwirth
Journal:  Antimicrob Agents Chemother       Date:  2011-08-01       Impact factor: 5.191

Review 2.  Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.

Authors:  J M Duggan; S J Goldstein; C E Chenoweth; C A Kauffman; S F Bradley
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

3.  Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases.

Authors:  Daniel Tena; Nora Mariela Martínez; Cristina Losa; Sonia Solís
Journal:  Scand J Infect Dis       Date:  2013-12-11

4.  Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989-2003).

Authors:  Gabriel Aisenberg; Kenneth V Rolston; Amar Safdar
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

5.  Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases.

Authors:  J Gómez-Cerezo; I Suárez; J J Ríos; P Peña; M J García de Miguel; M de José; O Monteagudo; P Linares; A Barbado-Cano; J J Vázquez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-16       Impact factor: 3.267

  5 in total
  3 in total

1.  Achromobacter xylosoxidans Bacteremia in a Liver Transplant Patient: A Case Report and Literature Review.

Authors:  Munsef Barakat; Jamal Sajid
Journal:  Cureus       Date:  2022-06-17

2.  Nosocomial Achromobacter xylosoxidans Infection Presenting as a Cavitary Lung Lesion in a Lung Cancer Patient.

Authors:  Vinoja Sebanayagam; Paul Nguyen; Mo'ath Nassar; Ayman Soubani
Journal:  Cureus       Date:  2020-08-17

3.  Characterization of Novel Lytic Bacteriophages of Achromobacter marplantensis Isolated from a Pneumonia Patient.

Authors:  Hiu Tat Chan; Heng Ku; Ying Ping Low; Teagan Brown; Steven Batinovic; Mwila Kabwe; Steve Petrovski; Joseph Tucci
Journal:  Viruses       Date:  2020-10-08       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.